Joslin Diabetes Center Investigator Rohit N. Kulkarni, MD, PhD, Awarded $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research
Joslin Diabetes Center Investigator Rohit N. Kulkarni, MD, PhD, Awarded $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research . Learn more about this honorary award.
Read more on Joslin Diabetes Center Investigator Rohit N. Kulkarni, MD, PhD, Awarded $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research
Four Women Joslin Investigators are Named to the 2024 WIELD Trailblazers: Women Shaping Diabetes and Metabolism Research and Care
Joslin Diabetes Center Principal Investigators Drs. Susan Bonner-Weir, Laurie Goodyear, Jean Schaffer and Yu-Hua Tseng were named to a 2024 WIELD Trailblazers list.
Read more on Four Women Joslin Investigators are Named to the 2024 WIELD Trailblazers: Women Shaping Diabetes and Metabolism Research and Care
More Than Half of Patients with Vision-Threatening Condition Unaware They Have It
Joslin Diabetes Center investigators’ study finds discrepancies between participants’ eye health status and their self-reported eye health. Read more.
Read more on More Than Half of Patients with Vision-Threatening Condition Unaware They Have It
Weight-Loss Surgery Provides Superior Long-Term Benefits For Patients With Type 2 Diabetes, Study Finds
Researchers at Joslin Diabetes Center, report that people with type 2 diabetes who underwent bariatric surgery achieve better long-term blood glucose control. Learn more.
Read more on Weight-Loss Surgery Provides Superior Long-Term Benefits For Patients With Type 2 Diabetes, Study Finds
In Brief: Preventing Beta Cell Dysfunction
Researchers at Joslin Diabetes Center address that chronically high sugar levels that occur during the early development of diabetes can affect the ability of beta cells to produce insulin.
Read more on In Brief: Preventing Beta Cell Dysfunction
Shifting Focus: Investigators Describe Changes to Pancreatic β Cell at Onset of Type 1 Diabetes
Joslin Diabetes Center researchers describe changes to the pancreatic β cell at onset of type 1 diabetes. Learn more.
Read more on Shifting Focus: Investigators Describe Changes to Pancreatic β Cell at Onset of Type 1 Diabetes
Telehealth May Help Young Adults with Type 1 Diabetes Self-Manage Their Health Better
Joslin Diabetes Center researchers address many of the challenges young adults with Type 1 diabetes face by developing a program that leverages telehealth.
Read more on Telehealth May Help Young Adults with Type 1 Diabetes Self-Manage Their Health Better
Joslin Diabetes Center Physicians Recognized in Boston Magazine’s 2024 ‘Top Doctors’
BOSTON – Boston Magazine has named ten physicians from four medical specialties affiliated with Joslin Diabetes Center to its annual ‘Top Doctors’ guide. Drawing from a Castle Connolly Medical Ltd...
Read more on Joslin Diabetes Center Physicians Recognized in Boston Magazine’s 2024 ‘Top Doctors’
Joslin Elects New Board Chair and Three New Members to Joslin Diabetes Center Board of Trustees
Joslin Diabetes Center announces Martin Pasqualini, Managing Director, CCA Group and Trustee since 2019 as elected Board Chair.
Read more on Joslin Elects New Board Chair and Three New Members to Joslin Diabetes Center Board of Trustees
Important News from Joslin Diabetes Center
Dana-Farber and BIDMC form cancer collaboration, including proposal to build a new, dedicated adult cancer hospital at current Joslin Diabetes Center site.
Read more on Important News from Joslin Diabetes Center
Selected Spring 2023 Publications from Joslin Faculty
At Joslin, our researchers are making incredible discoveries that improve diabetes care and move us closer to a cure. Below are selected academic publications led by Joslin faculty issued in recent...
Read more on Selected Spring 2023 Publications from Joslin Faculty
Afternoon Exercise Linked with Greater Improvements in Blood Sugar Levels for Patients with Type 2 Diabetes
In an analysis of the Look AHEAD study, researchers found that participants who were physically active in the afternoon had greater reductions in blood sugar than those who were most active at other...
Read more on Afternoon Exercise Linked with Greater Improvements in Blood Sugar Levels for Patients with Type 2 Diabetes
Joslin and COVID-19 Vaccine(s)
Joslin does not have a supply of COVID-19 vaccine and therefore we are unable to offer it to patients. However, the vaccines are now widely available to anyone over the age of 6 months and both Joslin...
Read more on Joslin and COVID-19 Vaccine(s)
Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes
Joslin Diabetes Center researchers completed a phase 3 clinical trial of two different classes of oral agents for the treatment of type 2 diabetes in young people aged 10-17 years. Read about their findings.
Read more on Phase 3 Trial Finds Oral Empagliflozin Provided Safe Glycemic Control in Children with Type 2 Diabetes
Showing 1 - 15 of 413 Results
To make an adult care appointment, call 617-309-2400 or make an appointment online.